During the past decade, Royal Marsden Hospital - Chelsea, London conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 3 clinical trials were completed, i.e. on average, 23.1% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 3 clinical trials were completed. i.e. 150% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Royal Marsden Hospital - Chelsea, London" #1 sponsor was "European Organisation for Research and Treatment of Cancer - EORTC" with 7 trials, followed by "Institute of Cancer Research, United Kingdom" with 4 trials sponsored, "Eli Lilly and Company" with 1 trials sponsored, "Incyte Corporation" with 1 trials sponsored and "Royal Marsden NHS Foundation Trust" with 1 trials sponsored. Other sponsors include -3 different institutions and companies that sponsored additional 7 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Royal Marsden Hospital - Chelsea, London" #1 collaborator was "Cancer Research UK" with 2 trials as a collaborator, "Cancer Trials Ireland" with 2 trials as a collaborator, "ETOP IBCSG Partners Foundation" with 2 trials as a collaborator, "Astellas Pharma Europe Ltd." with 1 trials as a collaborator and "Australian and New Zealand Urogenital and Prostate Cancer Trials Group" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Royal Marsden Hospital - Chelsea, London" are "Any Stage of Any Thymic Malignancy" (1 trials), "Any Stage of Lung Cancer (Any Histotype)" (1 trials), "Any Stage of Malignant Pleural Mesothelioma" (1 trials), "Breast Neoplasm Female" (1 trials) and "Breast Neoplasms" (1 trials). Many other conditions were trialed in "Royal Marsden Hospital - Chelsea, London" in a lesser frequency.

Most popular intervention types in "Royal Marsden Hospital - Chelsea, London" are "Drug" (12 trials), "Radiation" (3 trials), "Other" (2 trials), "Biological" (1 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Enzalutamide" (2 trials), "Placebo" (2 trials), "3-dimensional conformal radiation therapy" (1 trials), "Abemaciclib" (1 trials) and "Bevacizumab" (1 trials). Other intervention names were less common.

The vast majority of trials in "Royal Marsden Hospital - Chelsea, London" are 12 trials for "All" genders, 2 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Royal Marsden Hospital - Chelsea, London". undefined are not yet recruiting, undefined are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Royal Marsden Hospital - Chelsea, London, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Royal Marsden Hospital - Chelsea, London, 0 "Phase 1" clinical trials were conducted, 7 "Phase 2" clinical trials and 7 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".